The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 84 (high attention) · dilution pressure high · listing risk low · governance risk low · runway n/a · strongest signal: Equity line (Aug 28, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going-concern language) coexists with live selling machinery (atm program, equity line, pipe, registered direct, shelf filed, offering (424b)). Base case is a discounted raise; the question is when, not if.
Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 11, 2026 | ▼ Shelf filed | S-3 filed 2026-09-11 filing | 35 |
| Sep 11, 2026 | ▼ ATM program | “atm” language in S-3 (S-3) filed 2026-09-11 filing | 34 |
| Sep 10, 2026 | ▼ Going-concern language | “going concern periodic” language in 10-K (10-K) filed 2026-09-10 filing | 33 |
| Aug 28, 2026 | ▼ Equity line | “equity line” language in 8-K (EX-10.1) filed 2026-08-28 filing | 51 |
| Aug 28, 2026 | ▼ Offering (424B) | 424B5 prospectus supplement 2026-08-28; 1 prior 424B filings in 12m filing | 48 |
| Aug 28, 2026 | ▼ ATM program | “atm” language in 424B5 (424B5) filed 2026-08-28 filing | 39 |
| Aug 28, 2026 | ▼ ATM program | “atm” language in 8-K (8-K) filed 2026-08-28 filing | 39 |
| Aug 28, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-08-28 (accepted 07:33 ET) filing | 34 |
| Aug 28, 2026 | ▼ Registered direct | “rdo” language in 8-K (8-K) filed 2026-08-28 filing | 34 |
| Aug 28, 2026 | ▼ Registered direct | “rdo” language in 424B5 (424B5) filed 2026-08-28 filing | 34 |
| Aug 28, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-4.2) filed 2026-08-28 filing | 33 |
| Aug 28, 2026 | ▼ PIPE | “pipe” language in 8-K (8-K) filed 2026-08-28 filing | 33 |
| Aug 27, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-08-27; 0 prior 424B filings in 12m filing | 30 |
SOBR SOBR Safe, Inc. · ADIL ADIAL PHARMACEUTICALS, INC. · GOVX GeoVax Labs, Inc. · SNTI Senti Biosciences Holdings, · PFSA Profusa, Inc. · DVLT Datavault AI Inc. · screener →